InsiderClue
Insiders · Profile

Sinha Vikas

Chief Financial Officer at Scholar Rock · See Remarks at Kalaris Therapeutics. Filing since 20 Jan 2022. CIK 0001337845

SRRK Scholar Rock Holding Corp Chief Financial Officer · 2 trades KLRS Kalaris Therapeutics, Inc. See Remarks · 38 trades
Company
Date
Role
Action
Shares
Amount
Of holding
SRRK Scholar Rock Holding Corp
16 Apr 2026
Chief Financial Officer
Sold at will
10,410
$516.07K
1.7%
SRRK Scholar Rock Holding Corp
13 Jan 2026
Chief Financial Officer
Sold at will
16,755
$715.44K
2.8%
KLRS Kalaris Therapeutics, Inc.
21 Feb 2025
See Remarks
Sold at will
303
$3.05K
0.6%
KLRS Kalaris Therapeutics, Inc.
23 Jan 2025
See Remarks
Sold at will
129
$1.23K
0.3%
KLRS Kalaris Therapeutics, Inc.
10 Jan 2025
See Remarks
Sold at will
979
$430.86
0.1%
KLRS Kalaris Therapeutics, Inc.
19 Nov 2024
See Remarks
Sold at will
3,186
$1.75K
0.3%
KLRS Kalaris Therapeutics, Inc.
5 Nov 2024
See Remarks
Sold at will
5,136
$4.44K
0.4%
KLRS Kalaris Therapeutics, Inc.
22 Oct 2024
See Remarks
Sold at will
1,882
$1.44K
0.2%
KLRS Kalaris Therapeutics, Inc.
21 Oct 2024
See Remarks
Sold at will
1,546
$1.20K
0.1%
KLRS Kalaris Therapeutics, Inc.
3 Oct 2024
See Remarks
Sold at will
940
$765.91
0.1%
KLRS Kalaris Therapeutics, Inc.
19 Aug 2024
See Remarks
Sold at will
3,159
$2.40K
0.3%
KLRS Kalaris Therapeutics, Inc.
5 Aug 2024
See Remarks
Sold at will
5,251
$3.86K
0.5%
KLRS Kalaris Therapeutics, Inc.
22 Jul 2024
See Remarks
Sold at will
1,858
$1.37K
0.2%
KLRS Kalaris Therapeutics, Inc.
19 Jul 2024
See Remarks
Sold at will
1,542
$1.16K
0.1%
KLRS Kalaris Therapeutics, Inc.
2 Jul 2024
See Remarks
Sold at will
939
$676.08
0.1%
KLRS Kalaris Therapeutics, Inc.
17 May 2024
See Remarks
Sold at will
3,143
$2.36K
0.3%
KLRS Kalaris Therapeutics, Inc.
3 May 2024
See Remarks
Sold at will
4,957
$3.95K
0.4%
KLRS Kalaris Therapeutics, Inc.
22 Apr 2024
See Remarks
Sold at will
1,857
$1.39K
0.2%
KLRS Kalaris Therapeutics, Inc.
19 Apr 2024
See Remarks
Sold at will
1,521
$1.14K
0.1%
KLRS Kalaris Therapeutics, Inc.
2 Apr 2024
See Remarks
Sold at will
885
$683.22
0.1%
KLRS Kalaris Therapeutics, Inc.
20 Feb 2024
See Remarks
Sold at will
2,893
$2.01K
0.3%
KLRS Kalaris Therapeutics, Inc.
5 Feb 2024
See Remarks
Sold at will
18,331
$12.28K
1.6%
KLRS Kalaris Therapeutics, Inc.
23 Jan 2024
See Remarks
Sold at will
3,205
$2.15K
0.3%
KLRS Kalaris Therapeutics, Inc.
4 Jan 2024
See Remarks
Sold at will
961
$614.08
0.1%
KLRS Kalaris Therapeutics, Inc.
17 Nov 2023
See Remarks
Sold on a plan
2,490
$4.06K
0.2%
KLRS Kalaris Therapeutics, Inc.
20 Oct 2023
See Remarks
Sold on a plan
1,475
$2.27K
0.1%
KLRS Kalaris Therapeutics, Inc.
19 Oct 2023
See Remarks
Sold on a plan
1,232
$1.95K
0.1%
KLRS Kalaris Therapeutics, Inc.
3 Oct 2023
See Remarks
Sold on a plan
755
$1.49K
0.1%
KLRS Kalaris Therapeutics, Inc.
17 Aug 2023
See Remarks
Sold on a plan
10,516
$26.24K
0.9%
KLRS Kalaris Therapeutics, Inc.
20 Jul 2023
See Remarks
Sold on a plan
1,437
$4.81K
0.1%
KLRS Kalaris Therapeutics, Inc.
19 Jul 2023
See Remarks
Sold on a plan
1,198
$4.27K
0.1%
KLRS Kalaris Therapeutics, Inc.
5 Jul 2023
See Remarks
Sold on a plan
2,983
$9.08K
0.3%
KLRS Kalaris Therapeutics, Inc.
20 Apr 2023
See Remarks
Sold on a plan
1,466
$5.31K
0.1%
KLRS Kalaris Therapeutics, Inc.
19 Apr 2023
See Remarks
Sold on a plan
1,217
$4.51K
0.1%
KLRS Kalaris Therapeutics, Inc.
20 Jan 2023
See Remarks
Sold, plan not stated
1,426
$7.34K
0.1%
KLRS Kalaris Therapeutics, Inc.
19 Jan 2023
See Remarks
Sold, plan not stated
5,111
$25.95K
0.5%
KLRS Kalaris Therapeutics, Inc.
19 Oct 2022
See Remarks
Sold, plan not stated
1,449
$13.56K
0.1%
KLRS Kalaris Therapeutics, Inc.
20 Jul 2022
See Remarks
Sold, plan not stated
1,432
$7.47K
0.2%
KLRS Kalaris Therapeutics, Inc.
20 Apr 2022
See Remarks
Sold, plan not stated
1,162
$7.77K
0.1%
KLRS Kalaris Therapeutics, Inc.
20 Jan 2022
See Remarks
Sold, plan not stated
6,450
$56.45K
0.7%
40 decisions on file.